Navigation Links
CareFusion Sponsors Global Summit of Patient Safety Leaders
Date:2/17/2010

SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Hospital executives and global health care leaders will gather in Nice, France on April 20 for a summit to address the clinical, operational and financial returns of investing in patient safety. This one-day Global Patient Safety Summit, convened during the International Forum on Quality and Safety in Health Care, is made possible by an educational grant from CareFusion, a leading global medical device company.

The Global Patient Safety Summit curriculum will include interactive panel discussions from experts on preventing health care-associated infections (HAIs), eliminating adverse drug events (ADEs) and maximizing the impact of health information technology for patient safety. The list of conference speakers include:  

  • Rene Amalberti, MD, PhD, Senior Advisor, Patient Safety, Haute Autorite de Sante, France
  • David W. Bates, MD, MSc, Chief of the Division of General Medicine and Medical Director of Clinical and Quality Analysis, Brigham and Woman's Hospital Medical Director of Clinical and Quality Analysis, Information Systems, Partners HealthCare System, Inc. Boston, Mass., U.S.; External Program Leader, Patient Safety Research, World Health Alliance for Patient Safety, World Health Organization
  • David Cousins, Professor, Head of Safe Medication Practice and Medical Devices, National Patient Safety Agency, London, England
  • Dennis Quaid, Actor and Patient Safety Advocate, Hollywood, Calif., U.S.
  • '/>"/>

SOURCE CareFusion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CareFusion Reports Second Quarter Results
2. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
3. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
4. CareFusion Will Host an Earnings Conference Call on Feb. 9 to Discuss the Results for the Second Quarter of Fiscal 2010
5. FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
6. Nonin Medical Announces Expanded Distribution Partnership With CareFusion
7. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
8. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
9. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
10. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
11. CareFusion Moves First Quarter Earnings Announcement to November 5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 MEI Pharma, Inc. ... on the clinical development of novel therapies for ... effects of the Company,s investigational drug candidate ME-344 ... when combined with a tyrosine-kinase inhibitor (TKI). In ... be a potent inhibitor of mitochondrial oxidative phosphorylation ...
(Date:5/4/2015)... 4, 2015  Geneia, a company of experienced ... to improve healthcare efficiencies, today announced a first-of-its-kind ... (BNRC) use Geneia,s advanced analytics solution coupled ... quality and lower the cost of patient care. ... claims and utilization data from multiple sources to ...
(Date:5/4/2015)... 2015 Intarcia Therapeutics, Inc. ... into the newly created role of Chief ... pharmaceutical executive with world-class experience – most recently ... service at industry leaders such as Pfizer and ... range of therapeutic areas, including: cardiovascular, metabolic, oncology, ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
(Date:5/4/2015)... In a continuing effort to remain ... Per Wickstrom, the founder of Choices Recovery in South ... “Salute to the Oscars” celebration held on February ... floor of the luxurious Beverly Hilton Hotel. , ... sustainable product placement in TV and film, this daylong ...
(Date:5/4/2015)... May 04, 2015 McNeil & ... announces the expansion of coverage for its Emergency ... provider of industry-tailored insurance and proactive risk management to ... we are dedicated to providing our customers with unparalleled ... many evolving needs. We are excited to launch over ...
(Date:5/4/2015)... Orange, NJ (PRWEB) May 04, 2015 ... non-profit organization devoted exclusively to funding innovative lymphoma research ... of education programs, outreach initiatives and patient services – ... at the historic Mayfair Farms in West Orange, NJ ... raised nearly $500,000 for innovative research programs through LRF. ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 METTLER ... The Importance of Data Integrity in a GXP ... as guest presenter. This webinar will be presented ... GMT). , Data integrity is a critical component ... to regulatory agencies. However, in recent years an ...
(Date:5/4/2015)... Seattle, WA (PRWEB) May 04, 2015 ... of a collaboration to facilitate development of NM108, a ... disorders that lead to blindness, including Diabetic Retinopathy. ... formulation platform developed by EyeCRO, which can deliver drugs ... a topical eyedrop. , Under the terms of ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3
... it is commonly thought that men with low IQs ... sexual deviance, new research has found the men may ... education previously taken. , A team of North ... without an intellectual disability and a history of sexual ...
... Following a spate of accidental infant,suffocation deaths in Detroit ... awarded a $25,000 grant to support a community-based,initiative called ... safe place for newborns to sleep. The grant is ... is to improve the health status,of all Michigan residents, ...
... and reduce risk of ... medication errors, ... to continually improve patient safety,and staff efficiency, Omnicell, Inc. (Nasdaq: ... and Grant Regional Health,Center, a leading healthcare provider, today announced the ...
... N.C., Oct. 16 As the pace ... their market research,groups to keep up. Effective ... by using customers, markets and competitors as,reference ... according to,research from benchmarking leader Best Practices, ...
... Herley Industries,Inc. (Nasdaq: HRLY ) announced today ... been awarded a contract valued at,approximately $5 million ... produce high power amplifiers for EDO,s CVRJ (CREW,Vehicle ... CEO, commented, "EDO has recently,announced awards with options ...
... vomiting, researchers say , TUESDAY, Oct. 16 (HealthDay News) ... sushi and sashimi -- increases the risk of infection ... severe stomach and intestinal problems such as diarrhea, cramping, ... emergency department, say two cases studies by Japanese researchers. ...
Cached Medicine News:Health News:'Corrective' sex education may make sexual offenders more dangerous 2Health News:Blue Cross Blue Shield of Michigan Awards Grant to Reduce Accidental Infant Suffocations in Wayne County 2Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 2Health News:Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems 3Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs 2Health News:Raw Seafood Poses Digestive Risks 2
... Eppendorf Multipurpose Centrifuges feature ... accommodate a variety of rotors ... are three centrifuges in one: ... centrifuge for cell harvesting; a ...
Inquire...
Inquire...
Inquire...
Medicine Products: